The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davodeau, F.
Right arrow Articles by Bonneville, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davodeau, F.
Right arrow Articles by Bonneville, M.

The Journal of Immunology, Vol 158, Issue 12 5603-5611, Copyright © 1997 by American Association of Immunologists

ARTICLES

Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains

F Davodeau, MA Peyrat, A Necker, R Dominici, F Blanchard, C Leget, J Gaschet, P Costa, Y Jacques, A Godard, H Vie, A Poggi, F Romagne and M Bonneville
INSERM U211, Institute of Biology, Nantes, France.

Several studies have demonstrated the existence of a murine NK1.1+ alphabeta T cell subset expressing V alpha14+ TCR alpha-chains with highly conserved invariant junctional sequences and able to secrete Th2 cytokines when exposed to CD1+ stimulator cells. In humans, alphabeta T cells carrying invariant V alpha24+ TCR alpha-chains highly homologous to those expressed by murine NK1.1 cells have been recently described. Here we show that these cells (referred to as V alpha24inv T cells) and murine NK1.1+ alphabeta T cells resemble each other in several ways. First, like their murine counterparts, T cells expressing high levels of V alpha24inv TCRs can be either CD4- CD8- double negative (DN) or CD4+, but they never express heterodimeric CD8 molecules. Second, most V alpha24inv T cells are brightly stained by NKRP1-specific mAb but not by mAb directed against other type II transmembrane proteins of the NK complex. Third, DN and particularly CD4+ V alpha24inv T cells are greatly enriched for IL-4 producers. The concomitant expression of highly conserved TCRs of a particular set of NK markers and of Th2 cytokines in human and murine alphabeta T cells suggests a coordinate acquisition of these phenotypic and functional properties. Furthermore, the relatively high frequency of human V alpha24inv T cells, which are presently shown to represent on average 1/500 PBL, and the high interindividual variations of the size of this cell subset under physiologic conditions go for a major role played by alphabeta T cells carrying invariant TCR in a large array of immune responses.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. Coppieters, K. Van Beneden, P. Jacques, P. Dewint, A. Vervloet, B. Vander Cruyssen, S. Van Calenbergh, G. Chen, R. W. Franck, G. Verbruggen, et al.
A Single Early Activation of Invariant NK T Cells Confers Long-Term Protection against Collagen-Induced Arthritis in a Ligand-Specific Manner
J. Immunol., August 15, 2007; 179(4): 2300 - 2309.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Thedrez, C. de Lalla, S. Allain, L. Zaccagnino, S. Sidobre, C. Garavaglia, G. Borsellino, P. Dellabona, M. Bonneville, E. Scotet, et al.
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells
Blood, July 1, 2007; 110(1): 251 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. Coppieters, P. Dewint, K. Van Beneden, P. Jacques, S. Seeuws, G. Verbruggen, D. Deforce, and D. Elewaut
NKT cells: manipulable managers of joint inflammation
Rheumatology, April 1, 2007; 46(4): 565 - 571.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. Emoto, I. Yoshizawa, Y. Emoto, M. Miamoto, R. Hurwitz, and S. H. E. Kaufmann
Rapid Development of a Gamma Interferon-Secreting Glycolipid/CD1d-Specific V{alpha}14+ NK1.1- T-Cell Subset after Bacterial Infection.
Infect. Immun., October 1, 2006; 74(10): 5903 - 5913.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Shimizu, M. Hidaka, N. Kadowaki, N. Makita, N. Konishi, K. Fujimoto, T. Uchiyama, F. Kawano, M. Taniguchi, and S.-i. Fujii
Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using {alpha}-Galactosylceramide-Loaded Murine Dendritic Cells.
J. Immunol., September 1, 2006; 177(5): 3484 - 3492.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Pozo, M. Vales-Gomez, N. Mavaddat, S. C. Williamson, S. E. Chisholm, and H. Reyburn
CD161 (Human NKR-P1A) Signaling in NK Cells Involves the Activation of Acid Sphingomyelinase
J. Immunol., February 15, 2006; 176(4): 2397 - 2406.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. K. Sandberg, C. A. Stoddart, F. Brilot, K. A. Jordan, and D. F. Nixon
Development of innate CD4+ {alpha}-chain variable gene segment 24 (V{alpha}24) natural killer T cells in the early human fetal thymus is regulated by IL-7
PNAS, May 4, 2004; 101(18): 7058 - 7063.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. J. Wajchman, C. W. Pierce, V. A. Varma, M. M. Issa, J. Petros, and K. E. Dombrowski
Ex Vivo Expansion of CD8+CD56+ and CD8+CD56- Natural Killer T Cells Specific for MUC1 Mucin
Cancer Res., February 1, 2004; 64(3): 1171 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Motsinger, A. Azimzadeh, A. K. Stanic, R. P. Johnson, L. Van Kaer, S. Joyce, and D. Unutmaz
Identification and Simian Immunodeficiency Virus Infection of CD1d-Restricted Macaque Natural Killer T Cells
J. Virol., July 15, 2003; 77(14): 8153 - 8158.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. L. Gansert, V. Kiebler, M. Engele, F. Wittke, M. Rollinghoff, A. M. Krensky, S. A. Porcelli, R. L. Modlin, and S. Stenger
Human NKT Cells Express Granulysin and Exhibit Antimycobacterial Activity
J. Immunol., March 15, 2003; 170(6): 3154 - 3161.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Capone, D. Cantarella, J. Schumann, O. V. Naidenko, C. Garavaglia, F. Beermann, M. Kronenberg, P. Dellabona, H. R. MacDonald, and G. Casorati
Human Invariant V{alpha}24-J{alpha}Q TCR Supports the Development of CD1d-Dependent NK1.1+ and NK1.1- T Cells in Transgenic Mice
J. Immunol., March 1, 2003; 170(5): 2390 - 2398.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
M. Araki, T. Kondo, J. E. Gumperz, M. B. Brenner, S. Miyake, and T. Yamamura
Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission
Int. Immunol., February 1, 2003; 15(2): 279 - 288.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. B. Gurney, O. O. Yang, S. B. Wilson, and C. H. Uittenbogaart
TCR{gamma}{delta}+ and CD161+ Thymocytes Express HIV-1 in the SCID-hu Mouse, Potentially Contributing to Immune Dysfunction in HIV Infection
J. Immunol., November 1, 2002; 169(9): 5338 - 5346.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. K. Sandberg, N. M. Fast, E. H. Palacios, G. Fennelly, J. Dobroszycki, P. Palumbo, A. Wiznia, R. M. Grant, N. Bhardwaj, M. G. Rosenberg, et al.
Selective Loss of Innate CD4+ V{alpha}24 Natural Killer T Cells in Human Immunodeficiency Virus Infection
J. Virol., June 27, 2002; 76(15): 7528 - 7534.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Takahashi, S. Chiba, M. Nieda, T. Azuma, S. Ishihara, Y. Shibata, T. Juji, and H. Hirai
Cutting Edge: Analysis of Human V{alpha}24+CD8+ NK T Cells Activated by {alpha}-Galactosylceramide-Pulsed Monocyte-Derived Dendritic Cells
J. Immunol., April 1, 2002; 168(7): 3140 - 3144.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Gays, M. Unnikrishnan, S. Shrestha, K. P. Fraser, A. R. Brown, C. M. G. Tristram, Z. M. A. Chrzanowska-Lightowlers, and C. G. Brooks
The Mouse Tumor Cell Lines EL4 and RMA Display Mosaic Expression of NK-Related and Certain Other Surface Molecules and Appear to Have a Common Origin
J. Immunol., May 15, 2000; 164(10): 5094 - 5102.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Takahashi, M. Nieda, Y. Koezuka, A. Nicol, S. A. Porcelli, Y. Ishikawa, K. Tadokoro, H. Hirai, and T. Juji
Analysis of Human V{alpha}24+ CD4+ NKT Cells Activated by {alpha}-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells
J. Immunol., May 1, 2000; 164(9): 4458 - 4464.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Matsuura, M. Kinebuchi, H.-Z. Chen, S. Katabami, T. Shimizu, Y. Hashimoto, K. Kikuchi, and N. Sato
NKT Cells in the Rat: Organ-Specific Distribution of NK T Cells Expressing Distinct V{alpha}14 Chains
J. Immunol., March 15, 2000; 164(6): 3140 - 3148.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. J. Pittet, D. E. Speiser, D. Valmori, J.-C. Cerottini, and P. Romero
Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression
J. Immunol., February 1, 2000; 164(3): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Kukreja
Autoimmunity and Diabetes
J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4371 - 4378.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
M. Han, L. Harrison, P. Kehn, K. Stevenson, J. Currier, and M. A. Robinson
Invariant or Highly Conserved TCR {alpha} Are Expressed on Double-Negative (CD3+CD4-CD8-) and CD8+ T Cells
J. Immunol., July 1, 1999; 163(1): 301 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Kawano, Y. Tanaka, E. Shimizu, Y. Kaneko, N. Kamata, H. Sato, H. Osada, S. Sekiya, T. Nakayama, and M. Taniguchi
A novel recognition motif of human NKT antigen receptor for a glycolipid ligand
Int. Immunol., June 1, 1999; 11(6): 881 - 887.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Eberl, R. Lees, S. T. Smiley, M. Taniguchi, M. J. Grusby, and H. R. MacDonald
Tissue-Specific Segregation of CD1d-Dependent and CD1d-Independent NK T Cells
J. Immunol., June 1, 1999; 162(11): 6410 - 6419.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
E. P. Grant, M. Degano, J.-P. Rosat, S. Stenger, R. L. Modlin, I. A. Wilson, S. A. Porcelli, and M. B. Brenner
Molecular Recognition of Lipid Antigens by T Cell Receptors
J. Exp. Med., January 4, 1999; 189(1): 195 - 205.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. Brossay, M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg
CD1d-mediated Recognition of an alpha -Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution
J. Exp. Med., October 19, 1998; 188(8): 1521 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
F. M. Spada, Y. Koezuka, and S. A. Porcelli
CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells
J. Exp. Med., October 19, 1998; 188(8): 1529 - 1534.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. Burdin, L. Brossay, Y. Koezuka, S. T. Smiley, M. J. Grusby, M. Gui, M. Taniguchi, K. Hayakawa, and M. Kronenberg
Selective Ability of Mouse CD1 to Present Glycolipids: {alpha}-Galactosylceramide Specifically Stimulates V{alpha}14+ NK T Lymphocytes
J. Immunol., October 1, 1998; 161(7): 3271 - 3281.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Exley, S. Porcelli, M. Furman, J. Garcia, and S. Balk
CD161 (NKR-P1A) Costimulation of CD1d-dependent Activation of Human T Cells Expressing Invariant Valpha 24Jalpha Q T Cell Receptor alpha  Chains
J. Exp. Med., September 7, 1998; 188(5): 867 - 876.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. Brossay, S. Tangri, M. Bix, S. Cardell, R. Locksley, and M. Kronenberg
Mouse CD1-Autoreactive T Cells Have Diverse Patterns of Reactivity to CD1+ Targets
J. Immunol., April 15, 1998; 160(8): 3681 - 3688.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. Motsinger, D. W. Haas, A. K. Stanic, L. Van Kaer, S. Joyce, and D. Unutmaz
CD1d-restricted Human Natural Killer T Cells Are Highly Susceptible to Human Immunodeficiency Virus 1 Infection
J. Exp. Med., April 1, 2002; 195(7): 869 - 879.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.